Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Assets: 2017-2025

Historic Return on Assets for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Sep 2025 value amounting to -0.63%.

  • Rocket Pharmaceuticals' Return on Assets rose 1.00% to -0.63% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.63%, marking a year-over-year increase of 1.00%. This contributed to the annual value of -0.49% for FY2024, which is 3.00% down from last year.
  • Rocket Pharmaceuticals' Return on Assets amounted to -0.63% in Q3 2025, which was down 5.99% from -0.59% recorded in Q2 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Return on Assets peaked at -0.26% during Q1 2021, and registered a low of -0.64% during Q3 2024.
  • Over the past 3 years, Rocket Pharmaceuticals' median Return on Assets value was -0.53% (recorded in 2025), while the average stood at -0.54%.
  • Its Return on Assets has fluctuated over the past 5 years, first grew by 2bps in 2023, then fell by 15bps in 2024.
  • Rocket Pharmaceuticals' Return on Assets (Quarterly) stood at -0.33% in 2021, then decreased by 13bps to -0.46% in 2022, then increased by 2bps to -0.44% in 2023, then dropped by 14bps to -0.58% in 2024, then increased by 1bps to -0.63% in 2025.
  • Its Return on Assets was -0.63% in Q3 2025, compared to -0.59% in Q2 2025 and -0.53% in Q1 2025.